Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alzamend Neuro Inc (ALZN)

  • Business News
  • May 13, 2025, 12:00 UTC

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001“Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(9076)
  • Event(407)
  • SEC News(143782)
  • FDA Approval(8437)
  • Company Report(721)
  • Business News(100617)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin